These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [TBL] [Abstract][Full Text] [Related]
45. [Origin of drug names]. SheÄnbaum EM Feldsher Akush; 1983 Oct; 48(10):61-3. PubMed ID: 6557929 [No Abstract] [Full Text] [Related]
46. Proposed international nonproprietary names (Prop. INN): List 55. WHO Chron; 1986; 40(1 Suppl):1-20. PubMed ID: 3739337 [No Abstract] [Full Text] [Related]
47. Fluency of pharmaceutical drug names predicts perceived hazardousness, assumed side effects and willingness to buy. Dohle S; Siegrist M J Health Psychol; 2014 Oct; 19(10):1241-9. PubMed ID: 23740259 [TBL] [Abstract][Full Text] [Related]
48. Editorial: Standardization of drug names--a commentary. Lee A JAMA; 1974 Jul; 229(5):560-2. PubMed ID: 4406903 [No Abstract] [Full Text] [Related]
50. [International common denominations proposed by the World Health Organization]. Blanc P Ann Ist Super Sanita; 1967; 3(2):204-16. PubMed ID: 5619273 [No Abstract] [Full Text] [Related]
51. New countermeasures considered as drug counterfeiting grows. Schubert C Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355 [No Abstract] [Full Text] [Related]
52. [Drug nomenclature (I). What is the international common terminology and what is its use?]. Navarro FA Med Clin (Barc); 1995 Sep; 105(9):344-8. PubMed ID: 7500689 [No Abstract] [Full Text] [Related]
53. Drug labeling should be kept current. Rajpal A; Reidenberg MM Clin Pharmacol Ther; 2003 Jan; 73(1):4-6. PubMed ID: 12545138 [No Abstract] [Full Text] [Related]
54. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
55. Use of generic names--one name only. Wehrli A Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):315-6. PubMed ID: 2387657 [No Abstract] [Full Text] [Related]
56. "Passing off": a current legal issue in marketing of pharmaceuticals. Fink JL; Nelson AA Pharm Manage Comb Am J Pharm; 1979; 151(5):209-10. PubMed ID: 504375 [No Abstract] [Full Text] [Related]
57. [Guidelines and recommendations for labeling the products to be used in experiments in the clinical laboratories: WHO memoranda]. Bull World Health Organ; 1979; 57(3):431-5. PubMed ID: 314353 [No Abstract] [Full Text] [Related]
58. Why use generic names? Palmer DD Hawaii Med J; 1968; 27(4):321-4. PubMed ID: 5644836 [No Abstract] [Full Text] [Related]
59. Gene medication or genetic modification? The devil is in the details. Foss GS; Rogne S Nat Biotechnol; 2003 Nov; 21(11):1280-1. PubMed ID: 14595352 [No Abstract] [Full Text] [Related]
60. How INNs are created. Making drug names safer by contributing to INN selection. Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]